Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 1/2 6Phase 1 6Phase 3 4Phase NA 2Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2NET 1

Conditions

Neuroendocrine Tumors 18von Hippel-Lindau Disease 1Recurrence 1Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumor Grade 2 1Neuroblastoma 1Multiple Endocrine Neoplasia Type 1 1Meningioma 1Lung Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoid Tumor 1Adenoma, Islet Cell 1

Interventions

gallium Ga 68 dotatate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoid Tumor × NET × Clear all
NCT03623984 2023-09-11

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

University of Alabama at Birmingham

Phase EARLY_PHASE1 Withdrawn
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡